OTC : GRRMF
$0 (0.0%)
OTC
Uwe Ferdinand Röehrhoff
Medical - Instruments & Supplies
Healthcare
GRRMF
13528
DE
USD
1.48
0.81
0.48
0.13
-0.01
$2.32B
0.43
0.92
-10.08
-2.86
-$9.27
-$320.32M
-13.80%
-14.22%
-23.57%
-7.13%
-3.11
0.01
0.01
0/5
3 Analysts
%
About Gerresheimer AG (OTC:GRRMF) Stock
Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors. This segment also produces various plastic containers and closures, such as PET bottles, eye droppers, nasal sprays, nebulizers, and applicators, suitable for solid, liquid, and ophthalmic preparations, in addition to bottles for nutritional supplements. Its Primary Packaging Glass division specializes in essential glass packaging ... for both pharmaceutical and cosmetic industries. Offerings include infusion, dropper, and syrup bottles, injection vials, ampoules, and cartridges. This division also provides miniature bottles and glass containers for liquid food, spices, and spirits, as well as sophisticated packaging for fragrances, deodorants, skincare, wellness items, and diverse beauty and pharmaceutical products. The Advanced Technologies division is dedicated to pioneering smart drug delivery systems. A notable innovation is its micro-pumps, which empower patients to self-administer medications for conditions like Parkinson's disease or heart failure, catering to pharmaceutical and biotech clients. Established in 1864, the company's corporate headquarters are located in Düsseldorf, Germany.
Gerresheimer Q4 Earnings Call Highlights
2026-06-29 11:03:31
Gerresheimer ETR: GXI said it has completed a broad review of compliance and accounting matters, published its audited 2025 annual report and is now focused on selling Centor, refinancing debt and improving cash generation.
Frequently Asked Questions
What is the current Gerresheimer AG (GRRMF) stock price?
Gerresheimer AG(OTC:GRRMF) stock price is $33.35 in the last trading session. During the trading session, GRRMF stock reached the peak price of $56.75 while $19.165 was the lowest point it dropped to. The percentage change in GRRMF stock occurred in the recent session was 0.0% while the dollar amount for the price change in GRRMF stock was $0.
GRRMF's industry and sector of operation?
The OTC listed GRRMF is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
Who are the executives of GRRMF?
Uwe Ferdinand Röehrhoff
| Chairman of the Management Board & CEO
Wolf Uwe Lehmann
| Chief Financial Officer & Member of the Management Board
Carolin Nadilo
| Corporation Director of Investor Relations
Ueli Utzinger
| Group Senior Director Marketing & Communication
Hans-Norbert Topp
| Head of Moulded Glass Business Unit
How many employees does GRRMF have?
Number of GRRMF employees currently stands at 13528. GRRMF operates from Klaus-Bungert-Strasse 4, Düsseldorf, NW 40468, DE.
Link for GRRMF official website?
Official Website of GRRMF is: https://www.gerresheimer.com
How do I contact GRRMF?
GRRMF could be contacted at phone #49 211 61 81 00 and can also be accessed through its website. GRRMF operates from Klaus-Bungert-Strasse 4, Düsseldorf, NW 40468, DE.
How many shares of GRRMF are traded daily?
The average number of GRRMF shares traded daily for last 3 months was 22.
What is the market cap of GRRMF currently?
The market value of GRRMF currently stands at $1.15B with its latest stock price at $33.35